| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-04-03 | Sandrock Alfred President and CEO | Sale | -11,511 | -2.38%472,549 | $3.87 | $44,548 | View SEC filing | |
| 2026-02-26 | Swartz Robin COO & CBO | Sale | -6,458 | -3.13%199,738 | $3.77 | $24,347 | View SEC filing | |
| 2026-02-26 | Sandrock Alfred President and CEO | Sale | -14,197 | -2.85%484,060 | $3.79 | $53,807 | View SEC filing | |
| 2026-02-26 | Jorgensen Nathan D. Chief Financial Officer | Sale | -4,668 | -2.99%151,416 | $3.77 | $17,598 | View SEC filing | |
| 2026-02-26 | Carter Todd Alfred Chief Scientific Officer | Sale | -4,174 | -2.78%145,718 | $3.76 | $15,694 | View SEC filing | |
| 2026-02-20 | Swartz Robin COO & CBO | Sale | -3,882 | -1.85%206,196 | $3.44 | $13,354 | View SEC filing | |
| 2026-02-20 | Carter Todd Alfred Chief Scientific Officer | Sale | -3,301 | -2.15%149,892 | $3.44 | $11,355 | View SEC filing | |
| 2026-02-20 | Sandrock Alfred President and CEO | Sale | -11,732 | -2.30%498,257 | $3.41 | $40,006 | View SEC filing | |
| 2026-02-11 | Swartz Robin COO & CBO | Sale | -4,569 | -2.13%210,078 | $3.85 | $17,591 | View SEC filing | |
| 2026-02-11 | Sandrock Alfred President and CEO | Sale | -12,192 | -2.33%509,989 | $3.78 | $46,086 | View SEC filing | |
| 2026-02-11 | Carter Todd Alfred Chief Scientific Officer | Sale | -3,525 | -2.25%153,193 | $3.85 | $13,571 | View SEC filing | |
| 2025-10-07 | Jorgensen Nathan D. Chief Financial Officer | Sale | -7,666 | -5.83%123,834 | $4.78 | $36,643 | View SEC filing | |
| 2025-08-20 | Ferguson Toby Chief Medical Officer | Sale | -19,000 | -12.03%138,914 | $3.73 | $70,870 | View SEC filing | |
| 2025-04-04 | Ferguson Toby Chief Medical Officer | Sale | -10,086 | -6.00%157,914 | $3.43 | $34,595 | View SEC filing | |
| 2025-04-04 | Sandrock Alfred President and CEO | Sale | -10,885 | -2.46%430,931 | $3.43 | $37,336 | View SEC filing | |
| 2025-02-24 | Carter Todd Alfred Chief Scientific Officer | Sale | -3,305 | -4.08%77,718 | $4.26 | $14,079 | View SEC filing | |
| 2025-02-24 | Sandrock Alfred President and CEO | Sale | -11,702 | -3.79%296,816 | $4.24 | $49,616 | View SEC filing | |
| 2025-02-24 | Swartz Robin COO & CBO | Sale | -3,894 | -3.81%98,397 | $4.25 | $16,550 | View SEC filing | |
| 2025-02-12 | Carter Todd Alfred Chief Scientific Officer | Sale | -5,413 | -6.26%81,023 | $4.45 | $24,088 | View SEC filing | |
| 2025-02-12 | Swartz Robin COO & CBO | Sale | -6,950 | -6.36%102,291 | $4.45 | $30,928 | View SEC filing | |
| 2025-02-12 | Sandrock Alfred President & CEO | Sale | -16,644 | -5.12%308,518 | $4.45 | $74,066 | View SEC filing | |
| 2025-02-12 | Fahey Sandell Jacquelyn Chief Legal Officer | Sale | -4,358 | -5.07%81,643 | $4.45 | $19,393 | View SEC filing | |
| 2025-01-15 | Swartz Robin COO & CBO | Sale | -3,087 | -2.75%109,241 | $5.09 | $15,713 | View SEC filing | |
| 2025-01-15 | Carter Todd Alfred Chief Scientific Officer | Sale | -1,191 | -1.36%86,436 | $5.13 | $6,110 | View SEC filing | |
| 2024-12-26 | Swartz Robin COO&CBO | Sale | -6,500 | -5.47%112,328 | $5.65 | $36,725 | View SEC filing |
1-25 of 105
